M Scot Roberts insider trades
Open-market stock purchases and sales by M Scot Roberts, Chief Scientific Officer at Altimmune, Inc, from SEC Form 4 filings since May 4, 2017.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -26%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 31, 2026 | ALT Altimmune, Inc | Bought (not open market) | $2.1K |
| Feb 26, 2026 | ALT Altimmune, Inc | Bought (not open market) | — |
| Feb 26, 2026 | ALT Altimmune, Inc | Bought (not open market) | — |
| Feb 2, 2026 | ALT Altimmune, Inc | Sold (not open market) | $12.9K |
| Feb 2, 2026 | ALT Altimmune, Inc | Bought (not open market) | — |
| Jan 31, 2026 | ALT Altimmune, Inc | Bought (not open market) | $17.1K |
| Jan 30, 2026 | ALT Altimmune, Inc | Bought (not open market) | — |
| Jan 30, 2026 | ALT Altimmune, Inc | Sold (not open market) | $16K |
| Jan 27, 2026 | ALT Altimmune, Inc | Sold (not open market) | $29.3K |
| Jan 27, 2026 | ALT Altimmune, Inc | Bought (not open market) | — |
| Jan 25, 2026 | ALT Altimmune, Inc | Sold (not open market) | $24.1K |
| Jan 25, 2026 | ALT Altimmune, Inc | Bought (not open market) | — |
Companies traded
- ALT Altimmune, Inc: 1 buy, 4 sales, last Jul 31, 2026
- NASDAQ:ALT Altimmune, Inc: other filings, last May 4, 2017